StreetAlpha.app
Home › Stocks › BHC

Bausch Health Companies Inc. (BHC)

Healthcare
$8.47
▲ +0.53%
LAST CLOSE · NOV 17

Bausch Health develops and sells branded and generic medicines, nonprescription products and aesthetic medical devices. It last closed at $8.47 on Nov 17, up 0.53% on the day. The average 12-month price target from 3 analysts is $9.00 (+6.2% from the last close), with a high of $10.00 and a low of $8.00. Analyst consensus is Hold, based on the latest ratings from 3 firms (0 buy, 3 hold, 0 sell). In the past 30 days there were 3 dark pool prints totaling $3.5M, the largest $2.8M.

AI Auto Pilots
Is BHC in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$11.1B
+10.8% vs a year ago
Net income
−$841.0M
−332.3% vs a year ago
EPS (diluted)
−$2.25
−332.0% vs a year ago
Free cash flow
$1.9B
16.8% margin
Valuation
Market cap
$3.2B
374.3M shares
P/E
–
No P/E while losing money
Price to sales
0.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$2.5B
At Sep 30
Debt
$20.6B
At Sep 30
Shareholder equity
−$1.3B
Shares outstanding
374.3M
At Oct 23
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $8.4B$8.4BFY2021FY2022: $8.1B$8.1BFY2022FY2023: $8.8B$8.8BFY2023FY2024: $9.6B$9.6BFY2024FY2025: $10.3B$10.3BFY2025

From BHC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Hold
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
3firms
0 Buy3 Hold0 Sell
Each firm's latest rating on BHC in the past 90 days
Average 12-month target
$9.00
▲ 6.2% upside

Based on 3 analysts who set a price target on BHC in the past 90 days. The average target is $9.00, with a high of $10.00 and a low of $8.00, compared with the last close of $8.47.

$4$6$8$10PAST 12 TRADING DAYS12-MONTH TARGETSHIGH $10AVG $9LOW $8May 26LAST CLOSE+12 MO$4$6$8$10PAST 12 DAYSTARGETSHIGH $10AVG $9LOW $8May 26LAST CLOSE+12 MO
Highest target$10.00
Average target$9.00
Lowest target$8.00
Latest rating changes
BarclaysMaintained
Nov 11Hold$9
JefferiesMaintained
Oct 29Hold$8
RBC CapitalMaintained
Oct 29Hold$10
DateFirmActionRatingPrice target
Nov 11BarclaysMaintainedHold$9
Oct 29JefferiesMaintainedHold$8
Oct 29RBC CapitalMaintainedHold$10
Loading…

Technical Analysis

BHC · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 8% above its 20 day and 22% above its 50 day average. It is 31% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 67), near overbought. The nearest support is the Pivot at $8.38, and the nearest resistance the swing high (Nov 9) at $8.56.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 4.1%/day
Key levels
$9.0452 week high+6.7%
$8.56Pivot R1+1.1%
$8.56Swing high (Nov 9)+1.1%
$8.47Last close
$8.38Pivot−1.1%
$8.29Pivot S1−2.1%
$7.86Swing low (Nov 6)−7.2%
$7.7620 day average−8.4%
$6.6550 day average−21.5%
$6.19100 day average−26.9%
$5.82200 day average−31.3%
$4.3352 week low−48.9%
Indicators
RSI (14)67.48Strong, overbought above 70Neutral
MACD0.55Below its signal lineBearish
Stochastic71.6Middle of its rangeNeutral
ADX (14)40.3Strong uptrend
Williams %R-38.7Oversold below −80, overbought above −20Neutral
CCI (20)55.3Oversold below −100, overbought above 100Neutral
Rate of change+4.1%Change over 10 sessionsBullish
ATR (14)$0.35Typical daily range, 4.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for BHC

What happened before

See how BHC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow BHC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BHC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in BHC in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
3
Notional
$3.5M
Largest print
$2.8M
Loading…

BHC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲119 buying vs 85 selling
  • ▼Held by funds -6.5 pts
  • ▲Funds holding +11
  • ▲Superinvestors: 5 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding231220+5.0%
In funds' top 1045−20.0%
Held by funds59.8%66.3%−6.5 pts
New / increased41 / 7826 / 67+28.0%
Reduced / sold out58 / 2762 / 35−12.4%
Put/call ratio3.832.68+43.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BHC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BHC is in one of them and how their past BHC trades turned out.

BHC in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BHC in an article yet. Here's the latest on the wider market.

BHC Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Oct 7
Who traded BHC · since 2020
Latest 3 filings
$1K – $15KTraded Aug 27, 2020Filed Oct 7, 2020
$1K – $15KTraded Feb 24, 2020Filed Apr 28, 2020
$1K – $15KTraded Jan 6, 2020Filed Feb 25, 2020
PersonTypeAmountTradedFiledDelay
Susie LeeD · NVSell$1K – $15KAug 27, 2020Oct 7, 202041 d
Susie LeeD · NVBuy$1K – $15KFeb 24, 2020Apr 28, 202064 d
Susie LeeD · NVBuy$1K – $15KJan 6, 2020Feb 25, 202050 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Bausch Health Companies

Bausch Health is a specialty pharmaceutical and medical device company based in Quebec, Canada. It develops, makes and sells branded and generic prescription medicines, nonprescription products and aesthetic medical devices. Its main treatment areas include gastroenterology, hepatology, neurology and dermatology, and its products are sold in the United States and in many other countries across Asia, Europe, Latin America, Africa and the Middle East.

Headquarters
Quebec, Quebec, Canada